Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease model
Abstract Chronic lymphocytic leukemia (CLL) is a heterogeneous B cell malignancy characterized by the accumulation of functionally incompetent B lymphocytes. Despite the availability of highly effective treatments, CLL remains incurable, and the factors contributing to disease progression are not fu...
Saved in:
Main Authors: | Lisa Pfeuffer, Viola Siegert, Riccardo Trozzo, Katja Steiger, Roland Rad, Jürgen Ruland, Maike Buchner |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-025-86876-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry
by: Cecilia Bonolo de Campos, et al.
Published: (2025-02-01) -
The Impact of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Epithelial Ovarian Cancer
by: Samet Kirat, et al.
Published: (2022-12-01) -
Pathogenicity and Detection of Phytohormone (Gibberellic Acid and Indole Acetic Acid) Produced by Fusarium spp. that Causes Twisted Disease in Shallot
by: Ayu Lestiyani, et al.
Published: (2021-06-01) -
Seronegative autoimmune hepatitis
by: A. O. Buyeverov
Published: (2018-08-01) -
Evaluation of comorbidity burden on disease progression and mortality in patients with interstitial pneumonia with autoimmune features: A retrospective cohort study.
by: Elena K Joerns, et al.
Published: (2025-01-01)